Series A Completed
Vima Therapeutics Series A
US$60m raised
Announced 29 May 2025
Investors
Investors
- Atlas Venture
- Access Industries
- Canaan
Investors as the sources name them; a linked name has a FundComb profile.
- Company
- Vima Therapeutics
- Stage
- Series A
- Amount raised
- US$60m
- Company based in
- United States
- Sector
- Biotech
- Tags
- Biotech, Drug Development, Pharma
Similar rounds
- Goodfire Series A Apr 2025 · US$50m · led by Menlo Ventures
- OpenRouter Series A Jun 2025 · US$40m · led by Menlo Ventures
- Campfire Series A Jun 2025 · US$35m · led by Accel
- Wispr Series A Jun 2025 · US$30m · led by Menlo Ventures
- Grove Biopharma Series A Aug 2025 · US$30m · led by DCVC